Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTH | P32929 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24709385 | 0.85 | CTH (0.44) | CTHEGLN1TDP1ALDH1A1MAPT | |
| SCHEMBL2185099 | 0.79 | EGLN1 (0.41) | CTHEGLN1TDP1ALDH1A1MAPT | |
| SCHEMBL10391331 | 0.79 | — | — | |
| SCHEMBL65636 | 0.75 | EGLN1 (0.54) | CTHEGLN1TDP1ALDH1A1MAPT | |
| SCHEMBL597184 | 0.74 | EGLN1 (0.58) | CTHEGLN1TDP1ALDH1A1MAPT | |
| Aceturic Acid SCHEMBL28850599 | 0.74 | CTH (0.48) | CTHEGLN1TDP1ALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL18139583 | 0.73 | EGLN1 (0.52) | CTHEGLN1TDP1ALDH1A1MAPT | |
| Aceturic Acid SCHEMBL42918 | 0.73 | CTH (0.52) | CTHEGLN1TDP1ALDH1A1MAPT | |
| Aceturic Acid SCHEMBL5876 | 0.73 | — | — | |
| SCHEMBL4943507 | 0.72 | EGLN1 (0.56) | CTHEGLN1TDP1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190127769-A1 | UNSATURATED AMINO ACIDS | EVONIK DEGUSSA GMBH (DE) | 2019-05-02 | — | — | US | disclosed |
| EP-3452607-A1 | UNSATURATED AMINO ACIDS | Evonik Degussa GmbH (DE) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017191195-A1 | UNSATURATED AMINO ACIDS | EVONIK DEGUSSA GMBH (DE) | 2017-11-09 | — | — | WO | disclosed |
| EP-0018415-B1 | PROCESS FOR PRODUCING ALKYL 4-(ALKOXY METHYL PHOSPHINOYL)BUTYRATES AND ALKYL-(2-AMINO-4-(ALKOXY METHYL PHOSPHINOYL)) BUTYRATES | MEIJI SEIKA KAISHA LTD. (JP) | 1982-10-13 | — | — | EP | disclosed |
| EP-0018415-A1 | Process for producing alkyl 4-(alkoxy methyl phosphinoyl)butyrates and alkyl-(2-amino-4-(alkoxy methyl phosphinoyl)) butyrates | MEIJI SEIKA KAISHA LTD. (JP) | 1980-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127769-A1 | UNSATURATED AMINO ACIDS | POR, FADS1, MTR | CTH 483/4885EGLN1 560/4885TDP1 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.